https://www.news-medical.net/news/20221130/The-antibody-resistance-profile-and-viral-receptor-binding-affinity-of-SARS-CoV-2-Omicron-BQ1-BQ11-XBB-and-XBB1-subvariants.aspx
Researchers investigated the neutralizing antibody titers against the newly emergent BQ.1, BQ.1.1, XBB, and XBB.1 SARS-CoV-2 Omicron subvariants using sera from individuals with primary and booster COVID-19 vaccinations and previous SARS-CoV-2 infections.
Create an account or login to join the discussion